Atlas Trials

Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma

Clinical trial NCT04452292 · COMPLETED

Trial details

NCT number
NCT04452292
Sponsor
Charles Kunos
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Large-Cell Neuroendocrine Carcinoma
Start date
2021-09-14
Primary completion
2022-05-04
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.